Amneal Pharmaceuticals News

Earnings Call Summary | Amneal Pharmaceuticals(AMRX.US) Q1 2024 Earnings Conference

The following is a summary of the Amneal Pharmaceuticals, Inc. (AMRX) Q1 2024 Earnings Call Transcript:Financial Performance:Amneal Pharmaceuticals reported a Q1 2024 revenue of $659 million, an incre

moomoo AI22:55 ET · Conference Call

Amneal Stock Climbs on Q1 Report, Opioid Settlement Update

Seeking Alpha15:45 ET

Amneal Pharmaceuticals: A Strong Buy on Robust Q1 Performance and Promising IPX-203 Launch

TipRanks14:15 ET

Truist Securities Raises Amneal Pharmaceuticals' Price Target to $9 From $7, Maintains Buy Rating

Truist Securities Raises Amneal Pharmaceuticals' Price Target to $9 From $7, Maintains Buy Rating.

MT Newswires14:11 ET

Express News | CORRECTION: Amneal Reaffirms 2024 Revenue Guidance Of $2.55B-$2.65B Versus Consensus Of $2.60B, With Adjusted EPS of $0.53-$0.63 Compared To Guidance Of $0.58

Benzinga14:09 ET

Express News | Amneal Pharmaceuticals Shares Are Trading Higher After the Company Reported Better-than-expected Q1 2024 Adjusted EPS and Sales

BenzingaMay 3 11:54 ET

Drugmaker Amneal Agrees to $270 Million U.S. Opioid Settlement

Yahoo FinanceMay 3 10:52 ET

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

Health care stocks were mixed in pre-bell activity Friday, with the Health Care Select Sector SPDR Fund (XLV) 0.7% higher and the iShares Biotechnology ETF (IBB) recently inactive. Amgen (AMGN) was up

MT NewswiresMay 3 09:05 ET

Amneal Pharmaceuticals Q1 Adjusted Earnings, Revenue Climb

Amneal Pharmaceuticals (AMRX) reported Q1 adjusted earnings Friday of $0.14 per diluted share, up from $0.12 a year earlier. Analysts polled by Capital IQ estimated $0.09. Net revenue for the quarter

MT NewswiresMay 3 06:47 ET

Express News | Amneal Reaffirms 2024 Revenue Guidance Of $2.55B-$2.65B Versus Consensus Of $2.60B, With Adjusted EBITDA of $0.53-$0.63 Compared To Guidance Of $0.58

BenzingaMay 3 06:13 ET

Amneal Pharmaceuticals Sees 2024 Adj EPS 53c-Adj EPS 63c >AMRX

Amneal Pharmaceuticals Sees 2024 Adj EPS 53c-Adj EPS 63c >AMRX

Dow JonesMay 3 06:11 ET

Express News | Amneal Pharmaceuticals Inc Q1 Shr View $0.09, Rev View $619.0 Mln -- Lseg Ibes Data

ReutersMay 3 06:02 ET

GUIDANCE: (AMRX) AMNEAL PHARMACEUTICALS Forecasts Fiscal Year 2024 EPS Range $0.53 - $0.63

06:01 AM EDT, 05/03/2024 (MT Newswires) -- GUIDANCE: (AMRX) AMNEAL PHARMACEUTICALS Forecasts Fiscal Year 2024 EPS Range $0.53 - $0.63

MT NewswiresMay 3 06:01 ET

Earnings Flash (AMRX) AMNEAL PHARMACEUTICALS Reports Q1 Revenue $659.2M, Vs. Street Est of $619M

06:01 AM EDT, 05/03/2024 (MT Newswires) -- Earnings Flash (AMRX) AMNEAL PHARMACEUTICALS Reports Q1 Revenue $659.2M, vs. Street Est of $619M

MT NewswiresMay 3 06:01 ET

Express News | Amneal Pharmaceuticals Inc: Q1 2024 Net Revenue of $659 Mln; Gaap Net Loss of $92 Mln; Diluted Loss per Share of $0.30

ReutersMay 3 06:01 ET

Express News | Amneal Pharmaceuticals Inc: Affirming 2024 Full Year Guidance

ReutersMay 3 06:00 ET

Express News | Amneal Reports First Quarter 2024 Financial Results

ReutersMay 3 06:00 ET

Amneal Pharmaceuticals 1Q Rev $659.2M >AMRX

Amneal Pharmaceuticals 1Q Rev $659.2M >AMRX

Dow JonesMay 3 06:00 ET

Amneal Pharmaceuticals Has Reached Settlement in Principle on a Nationwide Opioids Settlement, Payable Over Ten Years >AMRX

Amneal Pharmaceuticals Has Reached Settlement in Principle on a Nationwide Opioids Settlement, Payable Over Ten Years >AMRX

Dow JonesMay 3 06:00 ET

Analysts Offer Insights on Healthcare Companies: Bio-Techne (TECH) and Amneal Pharmaceuticals (AMRX)

TipRanksMay 2 04:03 ET